Drug profile

The FDA adverse-event record for Animax Ointment

12 FDA reports name Animax Ointment, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#2307 of 2,679
by report volume (all drugs)
12
adverse-event reports
8.3%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Animax Ointment ranks #2299 of 2679 by total reports (12). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#2299
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Animax Ointment has 12 reports now versus 12 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Animax Ointment changes

Signature read: 12 reports place Animax Ointment in the lower third of FDA AER volume (#2307 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
1
Deaths Reported
8.3%
Death-coded share of reports

Active Ingredients

Animax Ointment

Administration Routes

TopicalUnknownAuricular (Otic)

Species Affected

Dog 8
Cat 4

Most Affected Breeds

Domestic Shorthair 3
Schnauzer - Miniature 1
Spitz - German Pomeranian 1
Retriever - Golden 1
Shepherd Dog - German 1
Siamese 1
Retriever - Labrador 1
Shih Tzu 1
Deutsche Dogge, Great Dane 1
Crossbred Canine/dog 1

Most Reported Reactions

Vomiting 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Skin scab 2
Skin lesion NOS 2
Weight loss 2
Unsettled 1
Uncomfortable 1
Bloody diarrhoea 1
Elevated liver enzymes 1
Not eating 1
Bloated 1
Itching 1

Outcome Breakdown

Ongoing
9 (75.0%)
Recovered/Normal
1 (8.3%)
Euthanized
1 (8.3%)
Outcome Unknown
1 (8.3%)

Animax Ointment: lower report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Animax Ointment (#2307 of 2,679 by report volume); death-coded 8.3%. PlainBreed drug row · report volume stamp 12 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →